Xavier Solanich

8.0k citations

37 papers · 384 indexed · h-index 9

Impact in

Rheumatology top 10%
- Eosinophilic Disorders and Syndromes
Infectious Diseases
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research

Papers in

Rheumatology 15
- Otitis Media and Relapsing Polychondritis 5
- Eosinophilic Disorders and Syndromes 4
Infectious Diseases 11
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 5

Co-authors: Albert Selva-O’Callaghan María Jesús Rodríguez‐Nieto Ernesto Trallero‐Araguás Fredeswinda Romero-Bueno Iago Pinal‐Fernandez Olga Sánchez‐Pernaute Takahisa Gono Nieves Plana
Journals: Annals of the Rheumatic Diseases (9 papers)Frontiers in Immunology (4 papers)Clinical Infectious Diseases (2 papers)Journal of Clinical Immunology (2 papers)Clinical Kidney Journal (1 paper)
Partner nations: Spain United States Palestinian Territory

In The Last Decade

Xavier Solanich

33 papers receiving 378 citations

Peers

Countries citing papers authored by Xavier Solanich

Since Specialization

Citations

This map shows the geographic impact of Xavier Solanich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Solanich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Solanich more than expected).

Fields of papers citing papers by Xavier Solanich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Solanich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Solanich. The network helps show where Xavier Solanich may publish in the future.

Co-authors

The 25 scholars most cited alongside Xavier Solanich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xavier Solanich Line = papers co-authored together Xavier Solanich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country Clinical Infectious Diseases ·Sandra Pérez‐Recio, Maria D. Grijota‐Camino, Jordi Guardiola, Xavier Juanola, J. Notario, Xavier Solanich, Francisco Rodríguez‐Moranta, Joan M. Nolla, Rosa Fornons‐Servent, Enrique Sánchez‐Pastor, M. Luque, Núria Sabé, Miguel Santín, (unknown), Alexandra Ruiz‐Cerulla, Javier Narváez, Carmen Gómez‐Vaquero, Laura Berbel-Arcobé, Cristina Trapero	2025	0
2	Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients Clinical Immunology ·Arnau Antolí, José Pablo Gómez-Vázquez, Àngels Sierra-Fortuny, Carla Bermudez-Carre, Mario Framil, Edgar Creus‐Bachiller, Julen Viana-Errasti, Paula Rofes, Gemma Rocamora-Blanch, Lara Hidalgo-Peña, Lydia García-Serrano, Raül Rigo‐Bonnin, Lídia Feliubadaló, Jesús Del Valle, Laura Calatayud, Francisco Morandeira, Conxi Lázaro, Xavier Solanich	2025	1
3	Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients Frontiers in Immunology ·Mario Framil, Lydia García-Serrano, Francisco Morandeira, Juan Francisco Luchoro, Arnau Antolí, José Pablo Gómez-Vázquez, Àngels Sierra-Fortuny, Xavier Solanich	2025	1
4	Automatic measurement of choroidal thickness with swept-source optical coherence tomography in chronic Vogt-Koyanagi-Harada disease: 3 years’ follow-up Journal of Ophthalmic Inflammation and Infection ·Liria Yamamoto-Rodríguez, Alexander Anduaga-Beramendi, Roger Mediavilla-Vallespín, Olaia Subirà, Pere García-Bru, Xavier Solanich, Luís Arias, J. Maria Caminal Mitjana, Olga García	2024	1
5	Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial Clinical Infectious Diseases ·Pierre Malchair, Jordi Giol, Vanesa García García, Orlando Rodrı́guez, José Carlos Ruibal, Alvaro Zarauza, Ferrán Llopis, Leire Matellán, Tania Bernal, Beatriz Solís, Aurema Otero, Thiago Carnaval, Hector Ignacio Jofré, Javier Jacob, Xavier Solanich, Arnau Antolí, Gemma Rocamora, Sebastián Videla	2023	6
6	Histiocitosis Medicina Clínica ·Gemma Rocamora-Blanch, Fina Climent, Xavier Solanich	2023	3
7	Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy Frontiers in Immunology ·Arnau Antolí, Gemma Rocamora-Blanch, Mario Framil, Virgínia Mas-Bosch, Sergio Navarro‐Velázquez, Carla Bermúdez, Sergio Martínez‐Yélamos, Eva Dopico, Laura Calatayud, Nadia García‐Muñoz, Luis Humberto Hernández-Benítez, Antoni Riera‐Mestre, Jordi Bas, Cristina Masuet‐Aumatell, Raül Rigo‐Bonnin, Francisco Morandeira, Xavier Solanich	2022	17
8	Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation Frontiers in Medicine ·Pere Trias‐Sabrià, Eduard Dorca Duch, María Molina‐Molina, Samantha Aso, Marta Díez-Ferrer, Alfredo Marín Muñiz, Jaume Bordas-Martínez, Joan Sabater‐Riera, Patricio Luburich, Belén del Río, Xavier Solanich, Jordi Dorca, Salud Santos, Guillermo Suárez-Cuartín	2022	4
9	Multiple Drug Regimen-Refractory Rosai–Dorfman–Destombes Disease Mimicking Relapsing Polychondritis Successfully Treated with Cobimetinib European Journal of Case Reports in Internal Medicine ·Kima López-Aldabe, Francesc Escrihuela-Vidal, Manel Tuells-Morales, Clàudia Llobera-Ris, Andrea Bauer-Alonso, Montserrat Cortés‐Romera, Laura Gràcia-Sánchez, M. Tormo-Ratera, Xavier Roura, Rosa Maria Penin-Mosquera, Xavier Corbella, Xavier Solanich	2022	2
10	Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit Clinical Biochemistry ·Raül Rigo‐Bonnin, Víctor-Daniel Gumucio-Sanguino, Xosé Pérez-Fernández, Luisa Corral, MariPaz Fuset-Cabanes, María Pons-Serra, Enrique Hernández-Jiménez, Salvador Ventura-Pedret, Enric Boza-Hernández, Mercè Gasa, Xavier Solanich, Joan Sabater‐Riera	2021	5
11	Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19 Frontiers in Immunology ·Xavier Solanich, Gardenia Vargas‐Parra, Caspar I. van der Made, Annet Simons, Janneke Schuurs-Hoeijmakers, Arnau Antolí, Jesús Del Valle, Gemma Rocamora-Blanch, Fernando Setién, Manel Esteller, Simon V. van Reijmersdal, Antoni Riera‐Mestre, Joan Sabater‐Riera, Gabriel Capellá, Frank L. van de Veerdonk, Ben van der Hoven, Xavier Corbella, Alexander Hoischen, Conxi Lázaro	2021	74
12	Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol Contemporary Clinical Trials Communications ·Xavier Solanich, Arnau Antolí, Núria Padullés Zamora, Marta Fanlo‐Maresma, Adriana Iriarte, Francesca Mitjavila, Olga Capdevila, (unknown), Joan Sabater‐Riera, Jordi Bas, Anna Mensa‐Vilaró, Jordí Niubó, Nahum Calvo, Santiago Bolívar, Raül Rigo‐Bonnin, Laura Arregui, Cristian Tebé, Pilar Hereu, Sebastián Videla, Xavier Corbella	2021	13
13	Cardiotoxicidad por vemurafenib en paciente con enfermedad de Erdheim-Chester REC CardioClinics ·Aurema Otero, Adriana Iriarte, Xavier Solanich, Roser Llop, Dolores Rodríguez	2020	0
14	Novel PGM3 compound heterozygous variants with IgE‐related dermatitis, lymphopenia, without syndromic features Pediatric Allergy and Immunology ·Ana García‐García, Monserrat Buendia Arellano, Àngela Deyà‐Martínez, Jaime Lozano Blasco, Mercedes Serrano, Ana Maria Van Den Rym, Blanca García‐Solis, Ana Esteve‐Solé, Yiyi Luo, Alexandru Vlagea, Xavier Solanich, Megan R. Fisher, Jonathan J. Lyons, Rebeca Pérez de Diego, Laia Alsina	2020	7
15	Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease Seminars in Arthritis and Rheumatism ·Fredeswinda Romero-Bueno, P. Díaz del Campo, Ernesto Trallero‐Araguás, Juan Carlos Ruiz‐Rodríguez, I. Castellví, María Jesús Rodríguez‐Nieto, María José Martínez-Becerra, Olga Sánchez‐Pernaute, Iago Pinal‐Fernandez, Xavier Solanich, Takahisa Gono, Miguel Á. González‐Gay, Nieves Plana, Albert Selva-O’Callaghan	2020	127
16	Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in Spain Clinical Kidney Journal ·María Quero, Juliana Draibe, Xavier Solanich, Inés Rama, Montserrat Gomà‐i‐Freixanet, Laura Martínez-Valenzuela, Xavier Fulladosa, Josep María Cruzado, Joan Torrás	2019	6
17	Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations Journal of Clinical Immunology ·Clara Franco‐Jarava, Elena Álvarez de la Campa, Xavier Solanich, Francisco Morandeira, Virgínia Mas-Bosch, Marina García-Prat, Xavier de la Cruz, Andrea Martín‐Nalda, Pere Soler‐Palacín, M. Hernández, Roger Colobrán	2017	11
18	Procoagulant microparticles are increased in patients with Behçet’s disease but do not define a specific subset of clinical manifestations Clinical Rheumatology ·Juan Carlos Mejía, Thaia Ortiz, Dolors Tàssies, Xavier Solanich, Antonio Vidaller, Ricard Cervera, Joan Carles Reverter, Gerard Espinosa	2015	8
19	Pulmonary Thromboembolism and Diffuse Alveolar Hemorrhage in Granulomatosis With Polyangiitis Vasculitis Respiratory Care ·Gabriel Moreno‐González, Luisa Corral, Joan Sabater‐Riera, Xavier Solanich, Rafael Máñez	2014	4
20	Enfermedad de Erdheim-Chester: estudio de 12 casos Medicina Clínica ·Montserrat Juanós Iborra, Albert Selva-O’Callaghan, Xavier Solanich, Antonio Vidaller-Palacín, Salvador Martí i Puig, Josep Maria Grau Junyent, Miquel Vilardell Tarrés	2012	4

About Xavier Solanich

Xavier Solanich is a scholar working on Rheumatology, Infectious Diseases, Immunology, Genetics and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 384 indexed citations. Recurring topics across this work include Vasculitis and related conditions (9 papers), COVID-19 Clinical Research Studies (8 papers), Otitis Media and Relapsing Polychondritis (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Eosinophilic Disorders and Syndromes (4 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). The work is most often cited by research in Rheumatology (127 citations), Infectious Diseases (106 citations), Immunology (102 citations), Epidemiology (162 citations) and Dermatology (39 citations). Xavier Solanich has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include Albert Selva-O’Callaghan, María Jesús Rodríguez‐Nieto, Ernesto Trallero‐Araguás, Fredeswinda Romero-Bueno, Iago Pinal‐Fernandez, Olga Sánchez‐Pernaute, Takahisa Gono, Nieves Plana, Juan Carlos Ruiz‐Rodríguez and I. Castellví. Their work appears in journals such as Annals of the Rheumatic Diseases, Frontiers in Immunology, Clinical Infectious Diseases, Journal of Clinical Immunology and Clinical Kidney Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact